Adma Biologics Inc. (NASDAQ:ADMA) gapped up prior to trading on Tuesday . The stock had previously closed at $5.32, but opened at $5.34. Adma Biologics shares last traded at $5.73, with a volume of 27,847 shares trading hands.

A number of equities research analysts recently issued reports on ADMA shares. Maxim Group dropped their price target on shares of Adma Biologics from $24.00 to $14.00 and set a “buy” rating on the stock in a research note on Monday, July 25th. Raymond James Financial Inc. cut shares of Adma Biologics from a “strong-buy” rating to a “market perform” rating in a research note on Monday, August 1st.

The company’s market cap is $74.09 million. The stock’s 50 day moving average price is $6.31 and its 200-day moving average price is $6.43.

Adma Biologics (NASDAQ:ADMA) last issued its quarterly earnings data on Friday, August 12th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by $0.11. Equities analysts expect that Adma Biologics Inc. will post ($1.76) earnings per share for the current fiscal year.

ADMA Biologics, Inc is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.